SEC Filing: Form 10-Q
Quarterly report [Sections 13 or 15(d)]
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Quarterly report [Sections 13 or 15(d)]
Initial statement of beneficial ownership of securities
General statement of acquisition of beneficial ownership
Statement of acquisition of beneficial ownership by individuals
Statement of acquisition of beneficial ownership by individuals
Filed: 2023-11-13 00:00:00 Filing Summary: Filing Summary Filing Details: SEC Filing Detail